Filing Details
- Accession Number:
- 0000914190-21-000193
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-06 16:35:06
- Reporting Period:
- 2021-06-30
- Accepted Time:
- 2021-07-06 16:35:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
707511 | Regenerx Biopharmaceuticals Inc | RGRX | Pharmaceutical Preparations (2834) | 521253406 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1125610 | J J Finkelstein | C/O Regenerx Biopharmaceuticals, Inc. 15245 Shady Grove Road, Suite 470 Rockville MD 20850 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-30 | 75,000 | $0.20 | 1,712,991 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Common Stock Warrant (right to buy) | Acquisiton | 2021-06-30 | 56,250 | $0.00 | 56,250 | $0.24 |
Common Stock | Series B Common Stock Warrant (right to buy) | Acquisiton | 2021-06-30 | 56,250 | $0.00 | 56,250 | $0.28 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
56,250 | 2021-06-30 | 2023-06-30 | No | 4 | P | Direct |
56,250 | 2021-06-30 | 2026-06-30 | No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $0.36 | 2022-06-30 | 500,000 | 500,000 | Direct | |
Common Stock | Stock Option (right to buy) | $0.64 | 2023-03-16 | 200,000 | 200,000 | Direct | |
Common Stock | Stock Option (right to buy) | $0.28 | 2027-09-01 | 150,000 | 150,000 | Direct | |
Common Stock | Stock Option (right to buy) | $0.21 | 2028-07-17 | 250,000 | 250,000 | Direct | |
Common Stock | Stock Option (right to buy) | $0.21 | 2029-05-15 | 650,000 | 650,000 | Direct | |
Common Stock | Stock Option (right to buy) | $0.30 | 2030-06-10 | 500,000 | 500,000 | Direct | |
Common Stock | Convertible Promissory Note (right to buy) | $0.12 | 2019-02-27 | 2024-02-27 | 104,167 | 0 | Direct |
Common Stock | Convertible Promissory Note (right to buy) | $0.12 | 2019-05-13 | 2024-05-13 | 104,167 | 0 | Direct |
Common Stock | Convertible Promissory Note (right to buy) | $0.36 | 2020-10-15 | 2025-10-15 | 27,840 | 0 | Direct |
Common Stock | Common Stock Warrant (right to buy) | $0.18 | 2019-08-27 | 2024-02-27 | 78,125 | 78,125 | Direct |
Common Stock | Common Stock Warrant (right to buy) | $0.18 | 2019-11-13 | 2024-05-13 | 78,125 | 78,125 | Direct |
Common Stock | Common Stock Warrant (right to buy) | $0.45 | 2021-04-15 | 2025-10-15 | 20,880 | 20,880 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2022-06-30 | 500,000 | 500,000 | Direct |
2023-03-16 | 200,000 | 200,000 | Direct |
2027-09-01 | 150,000 | 150,000 | Direct |
2028-07-17 | 250,000 | 250,000 | Direct |
2029-05-15 | 650,000 | 650,000 | Direct |
2030-06-10 | 500,000 | 500,000 | Direct |
2024-02-27 | 104,167 | 0 | Direct |
2024-05-13 | 104,167 | 0 | Direct |
2025-10-15 | 27,840 | 0 | Direct |
2024-02-27 | 78,125 | 78,125 | Direct |
2024-05-13 | 78,125 | 78,125 | Direct |
2025-10-15 | 20,880 | 20,880 | Direct |
Footnotes
- 100% vested.
- 62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
- 162,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
- 125,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.